cancer vaccine

June 29, 2020June 29, 2020

Cancer Vaccine Combo to be Tested in Triple Negative Breast Cancer

News

UbiVac and Bristol Myers Squibb have announced plans to collaborate on a clinical trial to test whether a combination therapy approach can boost cancer immunity in patients with advanced triple ... Read more

December 10, 2018

Phase 1/2 Trial Testing Combo of Bria-IMT and Immune Checkpoint Inhibitors Begins Dosing Breast Cancer Patients

News

BriaCell Therapeutics has started patient dosing in a Phase 1/2a clinical trial testing its immunotherapy candidate Bria-IMT — used in combination with the immune checkpoint inhibitors Keytruda (pembrolizumab) or Yervoy (ipilimumab) — ... Read more

April 19, 2017April 19, 2017

First Patient Dosed in Newest Stage of Study of Pexa-Vec and Chemo as Sold Tumor Fighter

News

The first patient has been dosed in the Phase 2 portion of a clinical trial evaluating a combination of the cancer vaccine Pexa-Vec and chemotherapy in solid tumor patients. The ... Read more

January 12, 2017

Dentritic-cell Vaccine Shows Promise in HER2-positive Early-stage Breast Cancer

News

A new cancer vaccine that uses a patient’s own immune-regulating dendritic cells to target the HER2 protein can activate the immune system and cause regression of early-stage HER2-positive breast cancer, according ... Read more

December 2, 2014December 2, 2014

Breast Cancer Vaccine Shows Promising Results According to Study

News

In a recent study titled “Safety and preliminary evidence of biological efficacy of a mammaglobin-A DNA vaccine in patients with stable metastatic breast cancer”, and published in the Clinical Cancer ... Read more

November 17, 2014October 18, 2016

Antibody Response to Generex’s AE37 Breast Cancer Vaccine Allows Reduced Relapse

Breast Cancer News, News

At the 29th Annual Meeting & Associated Programs of the Society for Immunotherapy of Cancer held November 6-9, a representative from Generex Biotechnology Corporation presented data detailing proof of concept ... Read more

November 14, 2014October 18, 2016

Galena’s NeuVax Breast Cancer Vaccine Administered to First Patient

Breast Cancer News, News

The first patient has been treated in the Galena Biopharam, Inc. phase 2 clinical trial addressing patients with high risk HER2 3+ and/or HER2 gene-amplified breast cancer. Treatment consists of ... Read more

September 19, 2014September 19, 2014

TapImmune Releases Positive Data on Phase I Clinical Trial in Ovarian and Breast Cancer

Breast Cancer News, News

TapImmune Inc. has reported that analysis of the interim data from the first 13 patients of its Phase I clinical trial, show that every patient developed an enhanced T-cell immune ... Read more